Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gentler IVF alternative tested for PCOS patients

NCT ID NCT07274202

First seen Jan 02, 2026 · Last updated Jun 22, 2026 · Updated 27 times

Summary

This study compares in vitro maturation (IVM) to conventional ovarian stimulation in 84 women with severe PCOS undergoing their first fertility treatment. The goal is to see which method causes less pain, fewer side effects, and better quality of life. Participants will fill out questionnaires at several points during treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PCOS (POLYCYSTIC OVARY SYNDROME) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

In vitro maturation (IVM) of oocytes

What this could lead to

If IVM works better, it could offer PCOS patients a gentler fertility treatment with fewer side effects and less pain.

What could go wrong

This is a small, early-stage trial (84 participants) measuring only patient-reported outcomes, not pregnancy success. IVM may not improve comfort or could have unknown drawbacks.

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.